Challenges of bringing a new sedative to market!

Current Opinion in Anaesthesiology
John W Sear

Abstract

The current review examines the success and failures of the development of new hypnotic compounds for the human market. One of the important aspects is that one of the key present agents, propofol, is considered by many anaesthesiologists as 'the ideal'. However, all drugs have adverse or side-effects. The last 30 years since the introduction of propofol has seen many new compounds evaluated; but as at the present time, only three agents may achieve a pivotal position in the market - fospropofol (a sedative agent which may have a role in endoscopic surgery); remimazolam (a short-acting benzodiazepine) whose development is also being focused on the sedation rather than anaesthesia market; and the pregnane steroid, alfaxalone (an anaesthetic agent first introduced in 1972, but withdrawn in 1984 because of adverse allergic reactions to the solvent, Cremophor EL) now solvented in a cyclodextrin. Studies of these three agents thus far have shown that none of them has any major adverse side-effects; all have properties which warrant further clinical evaluation.

Associated Clinical Trials

References

Sep 1, 1979·British Journal of Anaesthesia·J W Sear, C Prys-Roberts
Sep 1, 1979·British Journal of Anaesthesia·J W Sear, C Prys-Roberts
Dec 1, 1978·British Journal of Anaesthesia·M E Simpson
Sep 1, 1983·British Journal of Anaesthesia·D F Jones, C Prys-Roberts
Oct 29, 2002·Anesthesia and Analgesia·Mariusz G BanaszczykSheldon S Hendler
Sep 19, 2003·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Cosimo AltomareGaetano Liso
May 26, 2004·International Journal of Pharmaceutics·Adriana TrapaniGaetano Liso
Jun 13, 2006·Veterinary Anaesthesia and Analgesia·Pierre J FerréHervé P Lefebvre
Jun 23, 2007·Anesthesiology·Gavin J KilpatrickGary S Tilbrook
Nov 22, 2007·Pharmaceutical Research·François RavenelleDamon Smith
Dec 7, 2007·Chemical & Pharmaceutical Bulletin·Norimasa KanamitsuManabu Soga
Jun 14, 2008·British Journal of Anaesthesia·F RavenelleD C Smith
Mar 11, 2010·Advances in Experimental Medicine and Biology·Junya KuribayashiJunzo Takeda
Sep 17, 2010·Journal of Clinical Gastroenterology·Eric B Cohen, Nezam H Afdhal
Jan 10, 2012·Anesthesiology·J Robert SneydKaren Grimsehl
Feb 1, 2013·Critical Care : the Official Journal of the Critical Care Forum·Rile GeDouglas E Raines

❮ Previous
Next ❯

Citations

Mar 27, 2019·Expert Opinion on Drug Discovery·Bernd Antkowiak, Gerhard Rammes

❮ Previous
Next ❯

Methods Mentioned

BETA
sedation

Related Concepts

Related Feeds

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.

© 2022 Meta ULC. All rights reserved